<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29897452</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>14</Issue><PubDate><Year>2018</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.</ArticleTitle><Pagination><StartPage>2425</StartPage><EndPage>2442</EndPage><MedlinePgn>2425-2442</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddy142</ELocationID><Abstract><AbstractText>A distinguishing aspect of spinal and bulbar muscular atrophy (SBMA) is its androgen-dependence, possibly explaining why only males are clinically affected. This disease, which impairs neuromuscular function, is linked to a polyglutamine expansion mutation in the androgen receptor (AR). In mouse models of SBMA, motor dysfunction is associated with pronounced defects in neuromuscular transmission, including defects in evoked transmitter release (quantal content, QC) and fiber membrane excitability (based on the resting membrane potential, RMP). However, whether such defects are androgen-dependent is unknown. Thus, we recorded synaptic potentials intracellularly from adult muscle fibers of transgenic (Tg) AR97Q male mice castrated pre-symptomatically. Although castration largely protects both QC and the RMP of fibers, correlating with the protective effect of castration on motor function, significant deficits in QC and RMP remained. Surprisingly, comparable defects in QC and RMP were also observed in pre-symptomatic AR97Q males, indicating that such defects emerge early and are pre-clinical. Exposing asymptomatic Tg females to androgens also induces both motor dysfunction and comparable defects in QC and RMP. Notably, asymptomatic Tg females also showed significant deficits in QC and RMP, albeit less severe, supporting their pre-clinical nature, but also raising questions about the androgen-dependence of pre-clinical symptoms. In summary, current evidence indicates that disease progression depends on androgens, but early pathogenic events may be triggered by the mutant AR allele independent of androgens. Such early, androgen-independent disease mechanisms may also be relevant to females carrying the SBMA allele.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Youfen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Michigan State University, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halievski</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Michigan State University, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuno</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adachi</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Occupational and Environment Health School of Medicine, Yahatanishi-ku, Kitakyushu Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobue</LastName><ForeName>Gen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breedlove</LastName><ForeName>S Marc</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Michigan State University, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Cynthia L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Michigan State University, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS045195</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C410798">AR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000728" MajorTopicYN="N">Androgens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018485" MajorTopicYN="N">Muscle Fibers, Skeletal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29897452</ArticleId><ArticleId IdType="pmc">PMC6030880</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddy142</ArticleId><ArticleId IdType="pii">4980306</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sobue G., Hashizume Y., Mukai E., Hirayama M., Mitsuma T., Takahashi A. (1989) X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain, 112, 209&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt B.J., Greenberg C.R., Allingham-Hawkins D.J., Spriggs E.L. (2002) Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology, 59, 770&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A.P., Yu Z., Murray S., Peralta R., Low A., Guo S., Yu X.X., Cortes C.J., Bennett C.F., Monia B.P.. et al. (2014) Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep., 7, 774&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks D.A., Johansen J.A., Mo K., Rao P., Eagleson B., Yu Z., Lieberman A.P., Breedlove S.M., Jordan C.L. (2007) Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl. Acad. Sci. U. S. A., 104, 18259&#x2013;18264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes C.J., Ling S.C., Guo L.T., Hung G., Tsunemi T., Ly L., Tokunaga S., Lopez E., Sopher B.L., Bennett C.F.. et al. (2014) Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron, 82, 295&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Oki K., Halievski K., Vicente L., Xu Y., Zeolla D., Poort J., Katsuno M., Adachi H., Sobue G., Wiseman R.W.. et al. (2015) Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy. J. Appl. Physiol., 118, 941&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4385878</ArticleId><ArticleId IdType="pubmed">25663674</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraru G., D'Ascenzo C., Polo A., Palmieri A., Baggio L., Vergani L., Gellera C., Moretto G., Pegoraro E., Angelini C. (2008) Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J. Neurol. Sci., 264, 100&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan C.L., Lieberman A.P. (2008) Spinal and bulbar muscular atrophy: a motoneuron or muscle disease? Curr. Opin. Pharmacol., 8, 752&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2603477</ArticleId><ArticleId IdType="pubmed">18775514</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Sang C., Kobayashi Y., Doyu M., Sobue G. (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron, 35, 843&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahashi K., Katsuno M., Hung G., Adachi H., Kondo N., Nakatsuji H., Tohnai G., Iida M., Bennett C.F., Sobue G. (2015) Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet., 24, 5985&#x2013;5994.</Citation><ArticleIdList><ArticleId IdType="pubmed">26231218</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H., Katsuno M., Minamiyama M., Waza M., Sang C., Nakagomi Y., Kobayashi Y., Tanaka F., Doyu M., Inukai A.. et al. (2005) Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain, 128, 659&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">15659427</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha M.C., Pousinha P.A., Correia A.M., Sebastiao A.M., Ribeiro J.A. (2013) Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One, 8, e73846&#x2013;e73811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong L., Wang X., Choe D.W., Polley M., Burnett B.G., Bosch-Marce M., Griffin J.W., Rich M.M., Sumner C.J. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci., 29, 842&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2746673</ArticleId><ArticleId IdType="pubmed">19158308</ArticleId></ArticleIdList></Reference><Reference><Citation>Poort J.E., Rheuben M.B., Breedlove S.M., Jordan C.L. (2016) Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy. Hum. Mol. Genet., 25, 3768&#x2013;3783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5216617</ArticleId><ArticleId IdType="pubmed">27493028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp M.Q., Poort J.L., Baqri R.M., Lieberman A.P., Breedlove S.M., Miller K.E., Jordan C.L. (2011) Impaired motoneuronal retrograde transport in two models of SBMA implicates two sites of androgen action. Hum. Mol. Genet., 20, 4475&#x2013;4490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196895</ArticleId><ArticleId IdType="pubmed">21873607</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Halievski K., Henley C., Atchison W.D., Katsuno M., Adachi H., Sobue G., Breedlove S.M., Jordan C.L. (2016) Defects in Neuromuscular Transmission May Underlie Motor Dysfunction in Spinal and Bulbar Muscular Atrophy. J. Neuorsci., 36, 5094&#x2013;5106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854970</ArticleId><ArticleId IdType="pubmed">27147661</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudel J., Heckmann M. (2002) Quantal endplate currents from newborn to adult mice and the switch from embryonic to adult channel type. Neurosci. Lett., 326, 13&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">12052527</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurkat-Rott K., Fauler M., Lehmann-Horn F. (2006) Ion channels and ion transporters of the transverse tubular system of skeletal muscle. J. Muscle Res. Cell Motil., 27, 275&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">16933023</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlowski J., Lingrel J.B. (1988) Tissue-specific and developmental regulation of rat Na, K-ATPase catalytic alpha isoform and beta subunit mRNAs. J. Biol. Chem., 263, 10436&#x2013;10442.</Citation><ArticleIdList><ArticleId IdType="pubmed">2839491</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzyukevich T.L., Neumann J.C., Rindler T.N., Oshiro N., Goldhamer D.J., Lingrel J.B., Heiny J.A. (2013) Tissue-specific role of the Na, K-ATPase alpha2 isozyme in skeletal muscle. J. Biol. Chem., 288, 1226&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3543005</ArticleId><ArticleId IdType="pubmed">23192345</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Zhang J., Li K., Yang J., Yu H., Duan S., Jiang K., Li X. (2014) beta-Catenin regulates membrane potential in muscle cells by regulating the alpha2 subunit of Na, K-ATPase. Eur. J. Neurosci., 40, 2216&#x2013;2224.</Citation><ArticleIdList><ArticleId IdType="pubmed">24674304</ArticleId></ArticleIdList></Reference><Reference><Citation>Souccar C., Lapa A.J., do Valle J.R. (1982) The influence of testosterone on neuromuscular transmission in hormone sensitive mammalian skeletal muscles. Muscle Nerve, 5, 232&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">6283341</ArticleId></ArticleIdList></Reference><Reference><Citation>Oki K., Wiseman R.W., Breedlove S.M., Jordan C.L. (2013) Androgen receptors in muscle fibers induce rapid loss of force but not mass: implications for spinal bulbar muscular atrophy. Muscle Nerve, 47, 823&#x2013;834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015727</ArticleId><ArticleId IdType="pubmed">23629944</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold A.P., Gorski R.A. (1984) Gonadal steroid induction of structural sex differences in the central nervous system. Annu. Rev. Neurosci., 7, 413&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pubmed">6370082</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanman T.A., Bakar D., Badders N.M., Burke A., Kokkinis A., Shrader J.A., Joe G.O., Schindler A.B., Bott L.C., Harmison G.G.. et al. (2016) Sexual reassignment fails to prevent kennedy's disease. J. Neuromuscul. Dis., 3, 121&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">27854206</ArticleId></ArticleIdList></Reference><Reference><Citation>Korber C., Kuner T. (2016) Molecular machines regulating the release probability of synaptic vesicles at the active zone. Front Synaptic Neurosci., 8, 1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4773589</ArticleId><ArticleId IdType="pubmed">26973506</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolphin A.C. (2012) Calcium channel auxiliary alpha2delta and beta subunits: trafficking and one step beyond. Nat. Rev. Neurosci., 13, 542&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">22805911</ArticleId></ArticleIdList></Reference><Reference><Citation>Calloway N., Gouzer G., Xue M., Ryan T.A. (2015) The active-zone protein Munc13 controls the use-dependence of presynaptic voltage-gated calcium channels. Elife, 4, 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525472</ArticleId><ArticleId IdType="pubmed">26196145</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki T., Hirai H., Takahashi T. (2013) Activity-dependent neurotrophin signaling underlies developmental switch of Ca2+ channel subtypes mediating neurotransmitter release. J. Neurosci., 33, 18755&#x2013;18763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6618703</ArticleId><ArticleId IdType="pubmed">24285882</ArticleId></ArticleIdList></Reference><Reference><Citation>Halievski K., Henley C.L., Domino L., Poort J.E., Fu M., Katsuno M., Adachi H., Sobue G., Breedlove S.M., Jordan C.L. (2015) Androgen-dependent loss of muscle BDNF mRNA in two mouse models of SBMA. Exp. Neurol., 269, 224&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4446172</ArticleId><ArticleId IdType="pubmed">25929689</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto L.A., Lapa A.J., Souccar C. (1994) Prejunctional regulatory actions of androgens on a hormone sensitive muscle. Muscle Nerve, 17, 906&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pubmed">8041398</ArticleId></ArticleIdList></Reference><Reference><Citation>Nudler S.I., Pagani M.R., Urbano F.J., McEnery M.W., Uchitel O.D. (2005) Testosterone modulates Ca(v2.2) calcium channels' functional expression at rat levator ani neuromuscular junction. Neuroscience, 134, 817&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">15987667</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky N.B., Pennuto M., Smith R.B., Palazzolo I., Moore J., Nie Z., Neale G., Taylor J.P. (2010) Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron, 67, 936&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenman J.A. (1965) Effect of denervation on the resting membrane potential of healthy and dystrophic muscle. J. Neurol. Neurosurg. Psychiatry, 28, 525&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC495955</ArticleId><ArticleId IdType="pubmed">5866606</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein S.P. (1980) A comparative electrophysiological study of motor end-plate diseased skeletal muscle in the mouse. J. Physiol., 307, 453&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1283056</ArticleId><ArticleId IdType="pubmed">7205674</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson K. (2000) Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Int., 57, 838&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pubmed">10720937</ArticleId></ArticleIdList></Reference><Reference><Citation>Maqoud F., Cetrone M., Mele A., Tricarico D. (2017) Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: pharmacological perspectives. Physiol. Genomics, 49, 306&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">28455309</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricarico D., Camerino D.C. (2011) Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies. Front Pharmacol., 2, 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108473</ArticleId><ArticleId IdType="pubmed">21687503</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricarico D., Mele A., Camerino G.M., Bottinelli R., Brocca L., Frigeri A., Svelto M., George A.L. Jr., Camerino D.C. (2010) The KATP channel is a molecular sensor of atrophy in skeletal muscle. J. Physiol., 588, 773&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2834937</ArticleId><ArticleId IdType="pubmed">20064856</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricarico D., Montanari L., Conte Camerino D. (2003) Involvement of 3Na+/2K+ ATP-ase and Pi-3 kinase in the response of skeletal muscle ATP-sensitive K+ channels to insulin. Neuromuscul. Disord., 13, 712&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">14561494</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone V.A., Burge J., McDermott M.P., Smith P.C., Herr B., Tawil R., Pandya S., Kissel J., Ciafaloni E., Shieh P.. et al. (2016) Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology, 86, 1408&#x2013;1416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4831040</ArticleId><ArticleId IdType="pubmed">26865514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng F., Lee D.C., Schrumpf L.A., Mazurek M.E., Lee Lo V., Gill S.K., Maselli R.A. (2017) Effect of 3,4-diaminopyridine at the murine neuromuscular junction. Muscle Nerve, 55, 223&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">27251582</ArticleId></ArticleIdList></Reference><Reference><Citation>Quartel A., Turbeville S., Lounsbury D. (2010) Current therapy for Lambert-Eaton myasthenic syndrome: development of 3, 4-diaminopyridine phosphate salt as first-line symptomatic treatment. Curr. Med. Res. Opin., 26, 1363&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pubmed">20377318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionno M., Moyer M., Pollarine J., van Lunteren E. (2008) Inotropic effects of the K+ channel blocker 3,4-diaminopyridine on fatigued diaphragm muscle. Respir. Physiol. Neurobiol., 160, 45&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">17881299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadman R.I., Vrancken A.F., van den Berg L.H., van der Pol W.L. (2012) Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3. Neurology, 79, 2050&#x2013;2055.</Citation><ArticleIdList><ArticleId IdType="pubmed">23115209</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen J.A., Troxell-Smith S.M., Yu Z., Mo K., Monks D.A., Lieberman A.P., Breedlove S.M., Jordan C.L. (2011) Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy. Neurodegener. Dis., 8, 25&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030474</ArticleId><ArticleId IdType="pubmed">20689246</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin A.R. (1976) The effect of membrane capacitance on non-linear summation of synaptic potentials. J. Theor. Biol., 59, 179&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">181641</ArticleId></ArticleIdList></Reference><Reference><Citation>McLachlan E.M., Martin A.R. (1981) Non-linear summation of end-plate potentials in the frog and mouse. J. Physiol., 311, 307&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1275411</ArticleId><ArticleId IdType="pubmed">6267255</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Wang B., Long C., Wu G., Zheng H. (2007) Increased asynchronous release and aberrant calcium channel activation in amyloid precursor protein deficient neuromuscular synapses. Neuroscience, 149, 768&#x2013;778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2199265</ArticleId><ArticleId IdType="pubmed">17919826</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmqvist D., Quastel D.M. (1965) A quantitative study of end-plate potentials in isolated human muscle. J. Physiol., 178, 505&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1357310</ArticleId><ArticleId IdType="pubmed">5827910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz R., Cano R., Casanas J.J., Gaffield M.A., Betz W.J., Tabares L. (2011) Active zones and the readily releasable pool of synaptic vesicles at the neuromuscular junction of the mouse. J. Neurosci., 31, 2000&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6633039</ArticleId><ArticleId IdType="pubmed">21307238</ArticleId></ArticleIdList></Reference><Reference><Citation>Samigullin D., Bill C.A., Coleman W.L., Bykhovskaia M. (2004) Regulation of transmitter release by synapsin II in mouse motor terminals. J. Physiol., 561, 149&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1665329</ArticleId><ArticleId IdType="pubmed">15388780</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaffl M.W., Horgan G.W., Dempfle L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res., 30, 36e&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113859</ArticleId><ArticleId IdType="pubmed">11972351</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>